Review
Open access
Aug 2026
Mechanisms of resistance to antibody-drug conjugates in bladder cancer
This review systematically summarizes the major mechanisms underlying ADC resistance in BC and outlines potential strategies to overcome it, including the development of next-generation ADCs, combination therapies, and predictive biomarkers.
Kai Liu, Feixiang Xu, Chen-Yang Wu et al.
· Frontiers in Pharmacology · 0 citations